On the public citation graph
Simian Adenoviruses As Vaccine Vectors
0 signed · 145 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/eji.200737672openalex-snapshot
Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
inferredcites →https://doi.org/10.1002/jgm.1530openalex-snapshot
Creation of a panel of vectors based on ape adenovirus isolates
inferredcites →https://doi.org/10.1002/jmv.23546openalex-snapshot
Seroprevalence of neutralizing antibodies to human adenoviruses type‐5 and type‐26 and chimpanzee adenovirus type‐68 in healthy Chinese adults
inferredcites →https://doi.org/10.1007/978-1-62703-679-5_11openalex-snapshot
Engineering Adenovirus Genome by Bacterial Artificial Chromosome (BAC) Technology
inferredcites →https://doi.org/10.1007/s00262-016-1831-8openalex-snapshot
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer
inferredcites →https://doi.org/10.1016/j.vaccine.2003.08.029openalex-snapshot
Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector
inferredcites →https://doi.org/10.1016/j.vaccine.2007.07.035openalex-snapshot
Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein
inferredcites →https://doi.org/10.1016/j.vaccine.2009.03.080openalex-snapshot
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
inferredcites →https://doi.org/10.1016/j.vaccine.2010.12.087openalex-snapshot
Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
inferredcites →https://doi.org/10.1016/j.vaccine.2015.01.042openalex-snapshot
The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
inferredcites →https://doi.org/10.1016/j.vaccine.2015.08.016openalex-snapshot
Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71
inferredcites →https://doi.org/10.1016/j.virol.2004.03.047openalex-snapshot
Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses
inferredcites →https://doi.org/10.1016/j.virol.2005.10.042openalex-snapshot
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
inferredcites →https://doi.org/10.1016/j.virol.2010.07.043openalex-snapshot
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
inferredcites →https://doi.org/10.1016/j.virol.2013.05.041openalex-snapshot
Adenoviruses isolated from wild gorillas are closely related to human species C viruses
inferredcites →https://doi.org/10.1016/j.ymthe.2006.03.027openalex-snapshot
A Chimpanzee-Origin Adenovirus Vector Expressing the Rabies Virus Glycoprotein as an Oral Vaccine against Inhalation Infection with Rabies Virus
inferredcites →https://doi.org/10.1016/s0140-6736(08)61591-3openalex-snapshot
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
inferredcites →https://doi.org/10.1016/s1473-3099(15)00362-xopenalex-snapshot
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s1473-3099(15)00486-7openalex-snapshot
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
inferredcites →https://doi.org/10.1038/mt.2013.284openalex-snapshot
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
inferredcites →https://doi.org/10.1038/mt.2014.157openalex-snapshot
Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
inferredcites →https://doi.org/10.1038/sj.gt.3302675openalex-snapshot
Chimpanzee-origin adenovirus vectors as vaccine carriers
inferredcites →https://doi.org/10.1038/sj.gt.3302754openalex-snapshot
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes
inferredcites →https://doi.org/10.1038/sj.mt.6300078openalex-snapshot
A CD46-binding Chimpanzee Adenovirus Vector as a Vaccine Carrier
inferredcites →https://doi.org/10.1056/nejmc1505499openalex-snapshot
Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report
inferredcites →https://doi.org/10.1056/nejmoa1410863openalex-snapshot
Chimpanzee Adenovirus Vector Ebola Vaccine
inferredcites →https://doi.org/10.1056/nejmoa1411627openalex-snapshot
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
inferredcites →https://doi.org/10.1086/509258openalex-snapshot
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
inferredcites →https://doi.org/10.1086/587993openalex-snapshot
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B gag/pol/nef Vaccine in Healthy Adults
inferredcites →https://doi.org/10.1089/10430340460745838openalex-snapshot
Characterization of a Family of Chimpanzee Adenoviruses and Development of Molecular Clones for Gene Transfer Vectors
inferredcites →https://doi.org/10.1093/infdis/jir850openalex-snapshot
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
inferredcites →https://doi.org/10.1093/nar/gni035openalex-snapshot
Simple and highly efficient BAC recombineering using galK selection
inferredcites →https://doi.org/10.1101/gad.926401openalex-snapshot
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex
inferredcites →https://doi.org/10.1111/cei.12101openalex-snapshot
RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF
inferredcites →https://doi.org/10.1126/science.272.5267.1470openalex-snapshot
Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor
inferredcites →https://doi.org/10.1126/scitranslmed.3002925openalex-snapshot
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
inferredcites →https://doi.org/10.1126/scitranslmed.3003155openalex-snapshot
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
inferredcites →https://doi.org/10.1126/scitranslmed.3009185openalex-snapshot
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
inferredcites →https://doi.org/10.1126/scitranslmed.aac5745openalex-snapshot
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
inferredcites →https://doi.org/10.1128/cdli.11.2.351-357.2004openalex-snapshot
Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States
inferredcites →https://doi.org/10.1128/iai.00315-10openalex-snapshot
New Candidate Vaccines against Blood-StagePlasmodium falciparumMalaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1
inferredcites →https://doi.org/10.1128/iai.01187-13openalex-snapshot
Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites
inferredcites →https://doi.org/10.1128/jvi.01725-06openalex-snapshot
Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA NuclearExport
inferredcites →https://doi.org/10.1128/jvi.02309-07openalex-snapshot
Control of mRNA Export by Adenovirus E4orf6 and E1B55K Proteins during Productive Infection Requires E4orf6 Ubiquitin Ligase Activity
inferredcites →https://doi.org/10.1128/jvi.02950-14openalex-snapshot
Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors
inferredcites →https://doi.org/10.1128/jvi.57.3.833-838.1986openalex-snapshot
Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression
inferredcites →https://doi.org/10.1128/jvi.75.2.699-709.2001openalex-snapshot
Identification of Three Functions of the Adenovirus E4orf6 Protein That Mediate p53 Degradation by the E4orf6-E1B55K Complex
inferredcites →https://doi.org/10.1128/jvi.75.23.11603-11613.2001openalex-snapshot
Replication-Defective Vector Based on a Chimpanzee Adenovirus
inferredcites →https://doi.org/10.1136/bmjopen-2015-008748openalex-snapshot
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
inferredcites →https://doi.org/10.1177/1740774515621037openalex-snapshot
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
inferredcites →https://doi.org/10.1186/1743-422x-10-349openalex-snapshot
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
inferredcites →https://doi.org/10.1371/journal.pone.0031208openalex-snapshot
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
inferredcites →https://doi.org/10.1371/journal.pone.0040385openalex-snapshot
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
inferredcites →https://doi.org/10.1371/journal.pone.0101591openalex-snapshot
Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial
inferredcites →https://doi.org/10.1371/journal.pone.0107903openalex-snapshot
Assessment of Humoral Immune Responses to Blood-Stage Malaria Antigens following ChAd63-MVA Immunization, Controlled Human Malaria Infection and Natural Exposure
inferredcites →https://doi.org/10.1371/journal.pone.0115161openalex-snapshot
A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS
inferredcites →https://doi.org/10.1586/14760584.2016.1106319openalex-snapshot
Recombinant modified vaccinia virus Ankara-based malaria vaccines
inferredcites →https://doi.org/10.3201/eid1210.060078openalex-snapshot
Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
inferredcites →https://doi.org/10.4049/jimmunol.1202861openalex-snapshot
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
inferredcites →https://doi.org/10.4049/jimmunol.170.3.1416openalex-snapshot
A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4669153openalex-extracted
A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in Patients with Active Crohn's Disease
inferred← citeshttps://doi.org/10.1002/9781119467748.ch30openalex-snapshot
Pyogenic Infections of the CNS 1
inferred← citeshttps://doi.org/10.1002/bit.27945openalex-snapshot
Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs
inferred← citeshttps://doi.org/10.1002/iid3.827openalex-snapshot
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
inferred← citeshttps://doi.org/10.1002/jmv.26709openalex-snapshot
Interpretative immune targets and contemporary position for vaccine development against SARS‐CoV‐2: A systematic review
inferred← citeshttps://doi.org/10.1007/978-3-030-63761-3_31openalex-snapshot
The COVID-19 Vaccine Landscape
inferred← citeshttps://doi.org/10.1007/978-3-031-48408-7_15openalex-snapshot
12.1 In Focus: Novel Manufacturing Platforms for Pandemic Preparedness and Emergency Response
inferred← citeshttps://doi.org/10.1007/s00508-021-01835-wopenalex-snapshot
Profiles of current COVID-19 vaccines
inferred← citeshttps://doi.org/10.1007/s12275-022-1598-xopenalex-snapshot
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00040-2openalex-snapshot
Modern Production Strategies in the Vaccine Industry
inferred← citeshttps://doi.org/10.1016/b978-0-12-811924-2.00024-9openalex-snapshot
Recombinant Adenovirus Vectors as Mucosal Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-89821-8.00005-xopenalex-snapshot
Methods to mitigate immune response
inferred← citeshttps://doi.org/10.1016/b978-0-323-89821-8.00016-4openalex-snapshot
Xenogenic adenoviral vectors as vaccines
inferred← citeshttps://doi.org/10.1016/j.ab.2019.113568openalex-snapshot
Semi-quantification of antibody-dependent enhancement (ADE) in the uptake of Adenovirus serotype 5 into THP-1 cells
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104523openalex-snapshot
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
inferred← citeshttps://doi.org/10.1016/j.ejps.2026.107619openalex-snapshot
Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e34927openalex-snapshot
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
inferred← citeshttps://doi.org/10.1016/j.jaut.2021.102742openalex-snapshot
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data
inferred← citeshttps://doi.org/10.1016/j.jvacx.2020.100066openalex-snapshot
Emerging vaccine manufacturers are innovating for the next decade
inferred← citeshttps://doi.org/10.1016/j.jviromet.2020.113842openalex-snapshot
Attenuated porcine-derived type 2 bovine viral diarrhea virus as vector stably expressing viral gene
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106699openalex-snapshot
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.04.056openalex-snapshot
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.08.040openalex-snapshot
Report from an ICT 2022 workshop on toxicology for Covid19 vaccines: Industry, regulatory and CRO perspectives
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126441openalex-snapshot
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults
inferred← citeshttps://doi.org/10.1016/j.virol.2026.111049openalex-snapshot
Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro
inferred← citeshttps://doi.org/10.1016/s2666-5247(22)00126-4openalex-snapshot
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
inferred← citeshttps://doi.org/10.1021/acscentsci.1c00080openalex-snapshot
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
inferred← citeshttps://doi.org/10.1021/acsnano.2c00909openalex-snapshot
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
inferred← citeshttps://doi.org/10.1038/s41541-019-0113-9openalex-snapshot
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques
inferred← citeshttps://doi.org/10.1038/s41541-021-00356-xopenalex-snapshot
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
inferred← citeshttps://doi.org/10.1038/s41541-023-00620-2openalex-snapshot
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs
inferred← citeshttps://doi.org/10.1038/s41541-023-00674-2openalex-snapshot
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
inferred← citeshttps://doi.org/10.1038/s41541-024-00862-8openalex-snapshot
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines
inferred← citeshttps://doi.org/10.1038/s41541-024-00989-8openalex-snapshot
Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig
inferred← citeshttps://doi.org/10.1080/14760584.2019.1588113openalex-snapshot
A review of 65 years of human adenovirus seroprevalence
inferred← citeshttps://doi.org/10.1080/14760584.2022.2114900openalex-snapshot
COVID-19 and vaccination: myths vs science
inferred← citeshttps://doi.org/10.1080/21645515.2017.1383575openalex-snapshot
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
inferred← citeshttps://doi.org/10.1080/21645515.2023.2175558openalex-snapshot
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
inferred← citeshttps://doi.org/10.1080/21645515.2025.2514356openalex-snapshot
Developing the next-generation of adenoviral vector vaccines
inferred← citeshttps://doi.org/10.1093/infdis/jiad271openalex-snapshot
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
inferred← citeshttps://doi.org/10.1097/im9.0000000000000072openalex-snapshot
Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
inferred← citeshttps://doi.org/10.1111/cmi.13132openalex-snapshot
Strategies used by bacterial pathogens to cross the blood–brain barrier
inferred← citeshttps://doi.org/10.1111/imcb.12505openalex-snapshot
Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development
inferred← citeshttps://doi.org/10.1111/imm.12829openalex-snapshot
Novel viral vectors in infectious diseases
inferred← citeshttps://doi.org/10.1111/imm.13222openalex-snapshot
The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
inferred← citeshttps://doi.org/10.1111/jth.15485openalex-snapshot
To clot or not to clot? Ad is the question—Insights on mechanisms related to vaccine‐induced thrombotic thrombocytopenia
inferred← citeshttps://doi.org/10.1111/sji.70000openalex-snapshot
The COVID‐19 vaccine ChAdOx1 is opsonized by anti‐vector antibodies that activate complement and promote viral vector phagocytosis
inferred← citeshttps://doi.org/10.1128/spectrum.00907-26openalex-snapshot
An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms
inferred← citeshttps://doi.org/10.1139/cjm-2020-0465openalex-snapshot
Frontrunners in the race to develop a SARS-CoV-2 vaccine
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-21-0079openalex-snapshot
How Did We Get a COVID-19 Vaccine in Less Than 1 Year?
inferred← citeshttps://doi.org/10.1186/s13073-021-00859-1openalex-snapshot
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
inferred← citeshttps://doi.org/10.1371/journal.pntd.0006870openalex-snapshot
A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
inferred← citeshttps://doi.org/10.14293/s2199-1006.1.sor-.ppyj404.v1openalex-snapshot
Why acute inflammatory response can happen after Adenoviral Vector Vaccines; Is the interleukin 6 the secret and how circumvent that, Is by adding polyethylene glycol (PEG)?
inferred← citeshttps://doi.org/10.1586/14760584.2016.1106319openalex-snapshot
Recombinant modified vaccinia virus Ankara-based malaria vaccines
inferred← citeshttps://doi.org/10.1590/1678-4685-gmb-2022-0079openalex-snapshot
The use of adenoviral vectors in gene therapy and vaccine approaches
inferred← citeshttps://doi.org/10.2174/0929867328666210521164809openalex-snapshot
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection
inferred← citeshttps://doi.org/10.2174/1568026623666230825094341openalex-snapshot
A Critical Assessment of COVID-19 Genomic Vaccines
inferred← citeshttps://doi.org/10.2174/9789815080056123020004openalex-snapshot
Anti-Microbial Drugs for Emerging and Re-emerging Microbial Diseases: Paradigm in the 21st Century
inferred← citeshttps://doi.org/10.31080/asms.2020.05.0953openalex-snapshot
Why Acute Inflammatory Response Can Happen After Adenoviral Vector Vaccines; Is the Interleukin 6 the Secret and How Circumvent that, Is by Adding Polyethylene Glycol (PEG)?
inferred← citeshttps://doi.org/10.32350/bsr.42.iopenalex-snapshot
Systematic Review of the SARS-CoV-2 Viral Vector Vaccine AstraZeneca (Azd1222)
inferred← citeshttps://doi.org/10.3346/jkms.2021.36.e54openalex-snapshot
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
inferred← citeshttps://doi.org/10.3389/fimmu.2021.728513openalex-snapshot
Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal
inferred← citeshttps://doi.org/10.3389/fimmu.2021.763912openalex-snapshot
Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed Pigs
inferred← citeshttps://doi.org/10.3389/fimmu.2022.901372openalex-snapshot
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity
inferred← citeshttps://doi.org/10.3389/fphar.2021.778219openalex-snapshot
Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern
inferred← citeshttps://doi.org/10.3390/ijerph18041626openalex-snapshot
SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
inferred← citeshttps://doi.org/10.3390/microorganisms11020246openalex-snapshot
A Review on Zoonotic Pathogens Associated with Non-Human Primates: Understanding the Potential Threats to Humans
inferred← citeshttps://doi.org/10.3390/pharmaceutics13122091openalex-snapshot
Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application
inferred← citeshttps://doi.org/10.3390/v11040322openalex-snapshot
Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
inferred← citeshttps://doi.org/10.3390/v13081493openalex-snapshot
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
inferred← citeshttps://doi.org/10.3390/v15071605openalex-snapshot
Detection and Molecular Characterization of Adenoviruses in Captive and Free-Roaming African Green Monkeys (Chlorocebus sabaeus): Evidence for Possible Recombination and Cross-Species Transmission
inferred← citeshttps://doi.org/10.3390/v16060973openalex-snapshot
The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies
inferred← citeshttps://doi.org/10.3390/vaccines10071068openalex-snapshot
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
inferred← citeshttps://doi.org/10.3390/vaccines7020040openalex-snapshot
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
inferred← citeshttps://doi.org/10.3390/vaccines8020184openalex-snapshot
The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
inferred← citeshttps://doi.org/10.3390/vaccines9030262openalex-snapshot
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
inferred← citeshttps://doi.org/10.3390/vaccines9111249openalex-snapshot
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
inferred← citeshttps://doi.org/10.34178/jbth.v3i2.126openalex-snapshot
Vaccines’ Candidates Against SARS-CoV-2
inferred← citeshttps://doi.org/10.36233/0507-4088-188openalex-snapshot
Markers of antroponotic viral infections in vervet monkeys arrived from their natural habitat (Tanzania)
inferred← citeshttps://doi.org/10.36290/lek.2021.001openalex-snapshot
Possibilities and principles of vaccination against COVID-19
inferred← citeshttps://doi.org/10.4049/jimmunol.2100656openalex-snapshot
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity
inferred← citeshttps://doi.org/10.4062/biomolther.2020.178openalex-snapshot
COVID-19 Vaccine: Critical Questions with Complicated Answers
inferred← citeshttps://doi.org/10.70675/2191bb60zcd55z42a3zb9ddz096fdace9d13openalex-snapshot
Séroprévalence des anticorps neutralisants dirigés contre les adénovirus de types C5, D26 et B35 au Burkina Faso et au Tchad : impacts sur l’utilisation de vecteurs dérivés des Adénovirus dans un contexte de vaccination
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.